| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $33.5B | $32.4B | $31.2B | $31.7B | $30.1B | $6.0B | $8.1B | $8.1B |
| Cost of Revenue | $11.6B | $11.2B | $10.7B | $10.1B | $10.5B | $9.4B | $9.2B | $9.1B |
| Gross Profit | — | — | — | — | — | $3.7B | $5.7B | $5.7B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $10.8B | $10.7B | $10.4B | $10.3B | $10.1B | $10.1B | $10.4B | $10.0B |
| Operating Income | $6.0B | $5.1B | $5.5B | $5.8B | $4.5B | $4.8B | $6.3B | $6.7B |
| Net Income | $4.7B | $3.7B | $3.8B | $5.0B | $3.6B | $0.6B | $1.2B | $1.5B |
| EPS (Basic) | $3.63 | $2.77 | $2.83 | $3.75 | $2.68 | $0.48 | $0.87 | $1.08 |
| EPS (Diluted) | $3.61 | $2.76 | $2.82 | $3.73 | $2.66 | $0.48 | $0.87 | $1.07 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $91.7B | $90.0B | $90.9B | $91.0B | $93.1B | $90.7B | $89.7B | $91.4B |
| Current Assets | $23.8B | $21.9B | $21.7B | $23.1B | $22.5B | $22.0B | $22.0B | $23.0B |
| Cash & Equivalents | $2.2B | $1.3B | $1.5B | $3.7B | $3.6B | $4.1B | $4.4B | $3.7B |
| Total Liabilities | $43.4B | $39.6B | $39.3B | $38.3B | $41.5B | $39.8B | $39.5B | $40.6B |
| Current Liabilities | $12.9B | $10.8B | $9.1B | $12.4B | $8.5B | $10.4B | $8.5B | $10.1B |
| Stockholders' Equity | $48.0B | $50.2B | $51.5B | $52.6B | $51.4B | $50.7B | $50.1B | $50.7B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $7.0B | $6.8B | $6.0B | $7.3B | $6.2B | $7.2B | $7.0B | $4.7B |
| Investing Cash Flow | $-1.9B | $-2.4B | $-3.5B | $-1.7B | $-2.9B | $-3.2B | $-0.8B | $5.9B |
| Capital Expenditures | $1.9B | $1.6B | $1.5B | $1.4B | $1.4B | $1.2B | $1.1B | $1.1B |
| Financing Cash Flow | $-4.4B | $-4.5B | $-5.0B | $-5.3B | $-4.1B | $-4.2B | $-5.4B | $-12.0B |